The developmental disruptions of serotonin signaling may involved in autism during early brain development

Neuroscience

Volumn 267, Issue , 2014, Pages 1-10

  Yang, C J ^a   Tan, H P ^a   Du, Y J ^b  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Autism; Calcitonin gene related peptide; Hyperserotonemia; Hyposerotonemia; Oxytocin; Serotonin

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; OXYTOCIN; SEROTONIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; AUTISM; BRAIN DEVELOPMENT; CENTRAL NUCLEUS (AMYGDALA); DISEASE ASSOCIATION; HUMAN; HYPERSEROTONEMIA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTONIN BLOOD LEVEL; SEROTONIN BRAIN LEVEL; SIGNAL TRANSDUCTION; SOCIAL INTERACTION; BRAIN; DEVELOPMENTAL DISORDER; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AUTISTIC DISORDER; BRAIN; DEVELOPMENTAL DISABILITIES; HUMANS; SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84896305428     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.02.021     Document Type: Review

References (120)

1. Abell F., Krams M., Ashburner J., Passingham R., Friston K., Frackowiak R., Happé F., Frith C., Frith U. The neuroanatomy of autism: a voxel-based whole brain analysis of structural scans. Neuroreport 1999, 10:1647-1651.
2. Abramson R.K., Wright H.H., Carpenter R., Brennan W., Lumpuy O., Cole E., Young S.R. Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 1989, 19:397-407.
3. Adams R.B., Franklin R.G., Kveraga K., Ambady N., Kleck R.E., Whalen P.J., Hadjikhani N., Nelson A.J. Amygdala responses to averted vs direct gaze fear vary as a function of presentation speed. Soc Cogn Affect Neurosci 2012, 7:568-577.
4. Amaral D.G. The promise and the pitfalls of autism research: an introductory note for new autism researchers. Brain Res 2011, 1380:3-9.
5. Anderson G.M., Cook E.H., Blakely R.D. Serotonin rising. N Engl J Med 2009, 360:2580.
6. Anderson G.M., Hertzig M.E., McBride P. Brief report: platelet-poor plasma serotonin in autism. J Autism Dev Disord 2012, 42:1510-1514.
7. Asano E., Chugani D., Muzik O., Behen M., Janisse J., Rothermel R., Mangner T., Chakraborty P., Chugani H. Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology 2001, 57:1269-1277.
8. Association AP, DSM-IV. APATFo (1994) Diagnostic and statistical manual of mental disorders: DSM-IV: Amer Psychiatric Pub Inc.
9. Azmitia E.C., Singh J.S., Whitaker-Azmitia P.M. Increased serotonin axons (immunoreactive to 5-HT transporter) in postmortem brains from young autism donors. Neuropharmacology 2011, 60:1347-1354.
10. Bailey A., Luthert P., Dean A., Harding B., Janota I., Montgomery M., Rutter M., Lantos P. A clinicopathological study of autism. Brain 1998, 121:889-905.
11. Bailey A., Phillips W., Rutter M. Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives. J Child Psychol Psychiatry 1996, 37:89-126.
12. Baio J. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill Summ 2012, 61:1-19.
13. Barnea-Goraly N., Frazier T.W., Piacenza L., Minshew N.J., Keshavan M.S., Reiss A.L., Hardan A.Y. A preliminary longitudinal volumetric MRI study of amygdala and hippocampal volumes in autism. Prog Neuropsychopharmacol Biol Psychiatry 2014, 48:124-128.
14. Baron-Cohen S., Scott F.J., Allison C., Williams J., Bolton P., Matthews F.E., Brayne C. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 2009, 194:500-509.
15. Benes F.M., Taylor J.B., Cunningham M.C. Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: implications for the development of psychopathology. Cereb Cortex 2000, 10:1014-1027.
16. Berger M., Gray J.A., Roth B.L. The expanded biology of serotonin. Annu Rev Med 2009, 60:355-366.
17. Blazevic S., Colic L., Culig L., Hranilovic D. Anxiety-like behavior and cognitive flexibility in adult rats perinatally exposed to increased serotonin concentrations. Behav Brain Res 2012, 230:175-181.
18. Boccuto L., Chen C.-F., Pittman A.R., Skinner C.D., McCartney H.J., Jones K., Bochner B.R., Stevenson R.E., Schwartz C.E. Decreased tryptophan metabolism in patients with autism spectrum disorders. Mol Autism 2013, 4:16.
19. Bonnin A., Goeden N., Chen K., Wilson M.L., King J., Shih J.C., Blakely R.D., Deneris E.S., Levitt P. A transient placental source of serotonin for the fetal forebrain. Nature 2011, 472:347-350.
20. Bonnin A., Levitt P. Fetal, maternal and placental sources of serotonin and new implications for developmental programming of the brain. Neuroscience 2011, 197:1.
21. Boylan C.B., Blue M.E., Hohmann C.F. Modeling early cortical serotonergic deficits in autism. Behav Brain Res 2007, 176:94-108.
22. Brand T., Anderson G.M. The measurement of platelet-poor plasma serotonin: a systematic review of prior reports and recommendations for improved analysis. Clin Chem 2011, 57:1376-1386.
23. Butkevich I.P., Khozhai L.I., Mikhailenko V.A., Otellin V.A. Decreased serotonin level during pregnancy alters morphological and functional characteristics of tonic nociceptive system in juvenile offspring of the rat. Reprod Biol Endocrinol 2003, 1:96.
24. CÔté F., Fligny C., Bayard E., Launay J.-M., Gershon M.D., Mallet J., Vodjdani G. Maternal serotonin is crucial for murine embryonic development. Proc Natl Acad Sci 2007, 104:329-334.
25. Celada P., Puig M.V., Artigas F. Serotonin modulation of cortical neurons and networks. Front Integr Neurosci 2013, 7:25.
26. Chen J.J., Li Z., Pan H., Murphy D.L., Tamir H., Koepsell H., Gershon M.D. Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: abnormal intestinal motility and the expression of cation transporters. J Neurosci 2001, 21:6348-6361.
27. Chugani D. Role of altered brain serotonin mechanisms in autism. Mol Psychiatry 2002, 7:S16.
28. Chugani D.C., Muzik O., Behen M., Rothermel R., Janisse J.J., Lee J., Chugani H.T. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999, 45:287-295.
29. Chugani D.C., Muzik O., Rothermel R., Behen M., Chakraborty P., Mangner T., Da Silva E.A., Chugani H.T. Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys. Ann Neurol 1997, 42:666-669.
30. Cochran D.E., Sikoglu E.M., Fallon D., Kennedy D.N., Hodge S.M., Foley A., Yakutis L.J., Moore C.M., Frazier J.A. The role of glutamate and gaba in autism spectrum disorders: pilot results from a proton magnetic resonance spectroscopy study 2013.
31. Connors S.L., Matteson K.J., Sega G.A., Lozzio C.B., Carroll R.C., Zimmerman A.W. Plasma serotonin in autism. Pediatr Neurol 2006, 35:182-186.
32. Cook E., Courchesne R., Lord C., Cox N.J., Yan S., Lincoln A., Haas R., Courchesne E., Leventhal B.L. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997, 2:247-250.
33. Cook E.H., Charak D.A., Arida J., Spohn J.A., Roizen N.J., Leventhal B.L. Depressive and obsessive-compulsive symptoms in hyperserotonemic parents of children with autistic disorder. Psychiatry Res 1994, 52:25-33.
34. Cook E.H., Arora R.C., Anderson G.M., Berry-Kravis E.M., Yan S.-Y., Yeoh H., Sklena P.J., Charak D.A., Leventhal B.L. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 1993, 52:2005-2015.
35. Coon H., Dunn D., Lainhart J., Miller J., Hamil C., Battaglia A., Tancredi R., Leppert M.F., Weiss R., McMahon W. Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am J Med Genet Part B Neuropsychiatr Genet 2005, 135:42-46.
36. Cross S., Kim S.-J., Weiss L.A., Delahanty R.J., Sutcliffe J.S., Leventhal B.L., Cook E.H., Veenstra-VanderWeele J. Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology 2007, 33:353-360.
37. Davis E., Fennoy I., Laraque D., Kanem N., Brown G., Mitchell J. Autism and developmental abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc 1992, 84:315.
38. De Lacalle S., Saper C. Calcitonin gene-related peptide-like immunoreactivity marks putative visceral sensory pathways in human brain. Neuroscience 2000, 100:115-130.
39. Dempsie Y., Morecroft I., Welsh D.J., MacRitchie N.A., Herold N., Loughlin L., Nilsen M., Peacock A.J., Harmar A., Bader M. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice. Circulation 2008, 117:2928-2937.
40. Depolarization M. Developmental regulation of early serotonergic neuronal differentiation: the role of brain-derived neurotrophic factor. Dev Biol 1995, 1:169-182.
41. Dolen G., Darvishzadeh A., Huang K.W., Malenka R.C. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 2013, 501:179-184.
42. Gadad B.S., Hewitson L., Young K.A., German D.C. Neuropathology and animal models of autism: genetic and environmental factors. Autism Res Treat 2013, 2013.
43. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003, 4:1002-1012.
44. Gershon M., Dreyfus C., Pickel V., Joh T., Reis D. Serotonergic neurons in the peripheral nervous system: identification in gut by immunohistochemical localization of tryptophan hydroxylase. Proc Natl Acad Sci 1977, 74:3086-3089.
45. Gershon M.D. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol 2005, 39:S184-S193.
46. Goldberg J., Anderson G.M., Zwaigenbaum L., Hall G.B., Nahmias C., Thompson A., Szatmari P. Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. J Autism Dev Disord 2009, 39:97-104.
47. González É., Penedo L.A., Oliveira-Silva P., Campello-Costa P., Guedes R.C.A., Serfaty C.A. Neonatal tryptophan dietary restriction alters development of retinotectal projections in rats. Exp Neurol 2008, 211:441-448.
48. Gringras P. Practical paediatric psychopharmacological prescribing in autism. The potential and the pitfalls. Autism 2000, 4:229-247.
49. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., Santarelli L., Beck S., Hen R. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002, 416:396-400.
50. Guastella A.J., Einfeld S.L., Gray K.M., Rinehart N.J., Tonge B.J., Lambert T.J., Hickie I.B. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry 2010, 67:692-694.
51. Hadjikhani N. Serotonin, pregnancy and increased autism prevalence: is there a link?. Med Hypotheses 2010, 74:880-883.
52. Hanley H.G., Stahl S.M., Freedman D.X. Hyperserotonemia and amine metabolites in autistic and retarded children. Arch Gen Psychiatry 1977, 34:521.
53. Hertz-Picciotto I., Delwiche L. The rise in autism and the role of age at diagnosis. Epidemiology 2009, 20:84-90.
54. Hollander E., Bartz J., Chaplin W., Phillips A., Sumner J., Soorya L., Anagnostou E., Wasserman S. Oxytocin increases retention of social cognition in autism. Biol Psychiatry 2007, 61:498-503.
55. Hollander E., Novotny S., Hanratty M., Yaffe R., DeCaria C.M., Aronowitz B.R., Mosovich S. Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology 2003.
56. Hoyer D., Clarke D.E., Fozard J.R., Hartig P., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994, 46:157-203.
57. Inan M., Crair M.C. Development of cortical maps: perspectives from the barrel cortex. The Neuroscientist 2007, 13:49-61.
58. Insel T.R., Young L.J. Neuropeptides and the evolution of social behavior. Cur Opin Neurobiol 2000, 10:784-789.
59. Isaac R., Boura-Halfon S., Gurevitch D., Shainskaya A., Levkovitz Y., Zick Y. Selective Serotonin Reuptake Inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells. J Biol Chem 2013, 288:5682-5693.
60. Jørgensen H., Kjær A., Knigge U., Møller M., Warberg J. Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. J Neuroendocrinol 2003, 15:564-571.
61. Kahne D., Tudorica A., Borella A., Shapiro L., Johnstone F., Huang W., Whitaker-Azmitia P.M. Behavioral and magnetic resonance spectroscopic studies in the rat hyperserotonemic model of autism. Physiol Behav 2002, 75:403-410.
62. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011, 68:444.
63. Klempin F., Beis D., Mosienko V., Kempermann G., Bader M., Alenina N. Serotonin is required for exercise-induced adult hippocampal neurogenesis. J Neurosci 2013, 33:8270-8275.
64. Kocorowski L.H., Helmstetter F.J. Calcitonin gene-related peptide released within the amygdala is involved in Pavlovian auditory fear conditioning. Neurobiol Learn Mem 2001, 75:149-163.
65. Koren Z., Pfeifer Y., Sulman F. Distribution and placental transfer of C-14-serotonin in pregnant rats. Am J Obstet Gynecol 1966, 95:290.
66. Lagace D.C., Donovan M.H., DeCarolis N.A., Farnbauch L.A., Malhotra S., Berton O., Nestler E.J., Krishnan V., Eisch A.J. Adult hippocampal neurogenesis is functionally important for stress-induced social avoidance. Proc Natl Acad Sci 2010, 107:4436-4441.
67. Lam K.S., Aman M.G., Arnold L.E. Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabilities 2006, 27:254-289.
68. Laporta J., Peters T.L., Merriman K.E., Vezina C.M., Hernandez L.L. Serotonin (5-HT) affects expression of liver metabolic enzymes and mammary gland glucose transporters during the transition from pregnancy to lactation. PLoS One 2013, 8:e57847.
69. Lauder J.M. Ontogeny of the serotonergic system in the rat: serotonin as a developmental signala. Ann NY Acad Sci 1990, 600:297-313.
70. Leboyer M., Philippe A., Bouvard M., Guilloud-Bataille M., Bondoux D., Tabuteau F., Feingold J., Mouren-Simeoni M.-C., Launay J.-M. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry 1999, 45:158-163.
71. Lesurtel M., Graf R., Aleil B., Walther D.J., Tian Y., Jochum W., Gachet C., Bader M., Clavien P-A. Platelet-derived serotonin mediates liver regeneration. Science 2006, 312:104-107.
72. Levitt P., Rakic P. The time of genesis, embryonic origin and differentiation of the brain stem monoamine neurons in the rhesus monkey. Dev Brain Res 1982, 4:35-57.
73. Lidov H.G., Molliver M.E. An immunohistochemical study of serotonin neuron development in the rat: ascending pathways and terminal fields. Brain Res Bull 1982, 8:389-430.
74. McDougle C., Naylor S.T., Cohen D.J., Aghajanian G.K., Heninger G.R., Price L.H. Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 1996, 53:993.
75. McDougle C.J., Naylor S.T., Cohen D.J., Volkmar F.R., Heninger G.R., Price L.H. A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996, 53:1001.
76. McNamara I.M., Borella A.W., Bialowas L.A., Whitaker-Azmitia P.M. Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes. Brain Res 2008, 1189:203-214.
77. Meaney M., Diorio J., Francis D., LaRocque S., O'Donnell D., Smythe J., Sharma S., Tannenbaum B. Environmental regulation of the development of glucocorticoid receptor systems in the rat forebrain. The role of serotonin. Ann NY Acad Sci 1994, 746:260-274.
78. Mercier F., Kwon Y.C., Douet V. Hippocampus/amygdala alterations, loss of heparan sulfates, fractones and ventricle wall reduction in adult BTBR T+ tf/J mice, animal model for autism. Neurosci Lett 2012, 506:208-213.
79. Meyer-Lindenberg A., Domes G., Kirsch P., Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci 2011, 12:524-538.
80. Meyer R.R. A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders. Mol Autism 2013, 4:37.
81. Mitchell J.B., Iny L.J., Meaney M.J. The role of serotonin in the development and environmental regulation of type II corticosteroid receptor binding in rat hippocampus. Dev Brain Res 1990, 55:231-235.
82. Modahl C., Green L.A., Fein D., Morris M., Waterhouse L., Feinstein C., Levin H. Plasma oxytocin levels in autistic children. Biol Psychiatry 1998, 43:270-277.
83. Mulder E.J., Anderson G.M., Kemperman R.F., Oosterloo-Duinkerken A., Minderaa R.B., Kema I.P. Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals. Neuropsychobiology 2009, 61:27-32.
84. Munesue T., Yokoyama S., Nakamura K., Anitha A., Yamada K., Hayashi K., Asaka T., Liu H.X., Jin D., Koizumi K., Islam M.S., Huang J.J., Ma W.J., Kim U.H., Kim S.J., Park K., Kim D., Kikuchi M., Ono Y., Nakatani H., Suda S., Miyachi T., Hirai H., Salmina A., Pichugina Y.A., Soumarokov A.A., Takei N., Mori N., Tsujii M., Sugiyama T., Yagi K., Yamagishi M., Sasaki T., Yamasue H., Kato N., Hashimoto R., Taniike M., Hayashi Y., Hamada J., Suzuki S., Ooi A., Noda M., Kamiyama Y., Kido M.A., Lopatina O., Hashii M., Amina S., Malavasi F., Huang E.J., Zhang J., Shimizu N., Yoshikawa T., Matsushima A., Minabe Y., Higashida H. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci Res 2010, 67:181-191.
85. Murphy D., Daly E., Schmitz N., Toal F., Murphy K., Curran S., Erlandsson K., Eersels J., Kerwin R., Ell P. Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry 2006, 163:934-936.
86. Nanson J. Autism in fetal alcohol syndrome: a report of six cases. Alcohol Clin Exp Res 1992, 16:558-565.
87. Petrov T., Krukoff T.L., Jhamandas J.H. Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 1994, 277:289-295.
88. Piven J., Palmer P. Psychiatric disorder and the broad autism phenotype: evidence from a family study of multiple-incidence autism families. Am J Psychiatry 1999, 156:557-563.
89. Piven J., Tsai G., Nehme E., Coyle J.T., Chase G.A., Folstein S.E. Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord 1991, 21:51-59.
90. Posey D.J., Puntney J.I., Sasher T.M., Kem D.L., McDougle C.J. Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol 2004, 14:233-241.
91. Risch N., Herrell R., Lehner T., Liang K.-Y., Eaves L., Hoh J., Griem A., Kovacs M., Ott J., Merikangas K.R. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression. JAMA 2009, 301:2462-2471.
92. Ritvo E.R., Yuwiler A., Geller E., Ornitz E.M., Saeger K., Plotkin S. Increased blood serotonin and platelets in early infantile autism. Arch Gen Psychiatry 1970, 23:566.
93. Roth B.L. The serotonin receptors: from molecular pharmacology to human therapeutics 2006, Springer.
94. Rutter M. Genetic studies of autism: from the 1970s into the millennium. J Abnormal Child Psychol 2000, 28:3-14.
95. Schain R.J., Freedman D.X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961, 58:315-320.
96. Schmitt J.A., Jorissen B.L., Sobczak S., van Boxtel M.P., Hogervorst E., Deutz N.E., Riedel W.J. Tryptophan depletion impairs memory consolidation but improves focussed attention in healthy young volunteers. J Psychopharmacol 2000, 14:21-29.
97. Schultz R.T. Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int J Dev Neurosci 2005, 23:125-141.
98. Schwaber J., Sternini C., Brecha N., Rogers W., Card J. Neurons containing calcitonin gene-related peptide in the parabrachial nucleus project to the central nucleus of the amygdala. J Comp Neurol 1988, 270:416-426.
99. Scott M.M., Deneris E.S. Making and breaking serotonin neurons and autism. Int J Dev Neurosci 2005, 23:277-285.
100. Shemer A., Azmitia E., Whitaker-Azmitia P. Dose-related effects of prenatal 5-methoxytryptamine (5-MT) on development of serotonin terminal density and behavior. Dev Brain Res 1991, 59:59-63.
101. Shemer A., Whitaker-Azmitia P., Azmitia E. Effects of prenatal 5-methoxytryptamine and parachlorophenylalanine on serotonergic uptake and behavior in the neonatal rat. Pharmacol Biochem Behav 1988, 30:847-851.
102. Spivak B., Golubchik P., Mozes T., Vered Y., Nechmad A., Weizman A., Strous R.D. Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology 2004, 50:157-160.
103. Teng B.L., Nonneman R.J., Agster K.L., Nikolova V.D., Davis T.T., Riddick N.V., Baker L.K., Pedersen C.A., Jarstfer M.B., Moy S.S. Prosocial effects of oxytocin in two mouse models of autism spectrum disorders. Neuropharmacology 2013, 72:187-196.
104. Tordjman S., Gutknecht L., Carlier M., Spitz E., Antoine C., Slama F., Carsalade V., Cohen D., Ferrari P., Roubertoux P. Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry 2001, 6:434-439.
105. Vanhoutte P., Lüscher T. Serotonin and the blood vessel wall. J Hypertens Suppl 1986, 4:S29-S35.
106. Veenstra-VanderWeele J., Christian S.L., Cook J., Edwin H. Autism as a paradigmatic complex genetic disorder. Annu Rev Genomics Hum Genet 2004, 5:379-405.
107. Veenstra-VanderWeele J., Muller C.L., Iwamoto H., Sauer J.E., Owens W.A., Shah C.R., Cohen J., Mannangatti P., Jessen T., Thompson B.J., Ye R., Kerr T.M., Carneiro A.M., Crawley J.N., Sanders-Bush E., McMahon D.G., Ramamoorthy S., Daws L.C., Sutcliffe J.S., Blakely R.D. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. Proc Natl Acad Sci U S A 2012, 109:5469-5474.
108. Vered Y., Golubchik P., Mozes T., Strous R., Nechmad A., Mester R., Weizman A., Spivak B. The platelet-poor plasma 5-HT response to carbohydrate rich meal administration in adult autistic patients compared with normal controls. Hum Psychopharmacol Clin Exp 2003, 18:395-399.
109. Vitalis T., Cases O., Passemard S., Callebert J., Parnavelas J.G. Embryonic depletion of serotonin affects cortical development. Eur J Neurosci 2007, 26:331-344.
110. Walther D.J., Peter J.-U., Winter S., Höltje M., Paulmann N., Grohmann M., Vowinckel J., Alamo-Bethencourt V., Wilhelm C.S., Ahnert-Hilger G. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet α-granule release. Cell 2003, 115:851-862.
111. Waterhouse L., Fein D., Modahl C. Neurofunctional mechanisms in autism. Psychol Rev 1996, 103:457.
112. Whitaker-Azmitia P.M. Serotonin and brain development: role in human developmental diseases. Brain Res Bull 2001, 56:479-485.
113. Whitaker-Azmitia P.M. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?. Int J Dev Neurosci 2005, 23:75-83.
114. Whitaker-Azmitia P.M., Azmitia E.C. Autoregulation of fetal serotonergic neuronal development: role of high affinity serotonin receptors. Neurosci Lett 1986, 67:307-312.
115. 1 receptors. Dev Brain Res 1987, 33:285-289.
116. Wiggins J.L., Swartz J.R., Martin D.M., Lord C., Monk C.S. Serotonin transporter genotype impacts amygdala habituation in youth with autism spectrum disorders. Soc Cogn Affect Neurosci 2013, [Epub ahead of print].
117. Wiggs L., Stores G. Sleep patterns and sleep disorders in children with autistic spectrum disorders: insights using parent report and actigraphy. Dev Med Child Neurol 2004, 46:372-380.
118. Wu S., Jia M., Ruan Y., Liu J., Guo Y., Shuang M., Gong X., Zhang Y., Yang X., Zhang D. Positive association of the oxytocin receptor gene (OXTR) with autism in the Chinese Han population. Biol Psychiatry 2005, 58:74-77.
119. Zafeiriou D., Ververi A., Vargiami E. The serotonergic system: its role in pathogenesis and early developmental treatment of autism. Curr Neuropharmacol 2009, 7:150.
120. Zhang J., Dennis K.A., Darling R.D., Alzghoul L., Paul I.A., Simpson K.L., Lin R.C. Neonatal citalopram exposure decreases serotonergic fiber density in the olfactory bulb of male but not female adult rats. Front Cell Neurosci 2013, 7.